AMPLIFON | Stock ComparatorAMPLIFON
None
Overview
Sector
Medical Distribution
Strengths
- Price to book ratio (2.93) is lower than the sector mean (35.33).
- EV/EBITDA (7.73) is lower than the sector mean (40.52).
- EV/EBIT (16.83) is lower than the sector mean.
- Price to free cash flow (11.05) is lower than the sector mean.
- Strong EBITDA Margin of 23.01%.
Weaknesses
- No significant weaknesses identified based on the analyzed metrics.
Key Financial Data
| Indicator | Value |
|---|
| PER | 23.0 |
| EV/EBITDA | 7.7 |
| Price/Free Cash Flow' | 11.0 |
| ROIC | 19.1% |
| Net Debt/EBITDA | 1.7 |